红宝丽(002165) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥560,791,884.37, a decrease of 35.15% compared to the same period last year[4]. - Total operating revenue for the current period is CNY 1,891,952,827.48, a decrease of 27.3% compared to CNY 2,602,078,488.23 in the previous period[18]. - Total operating costs for the current period amount to CNY 1,923,378,869.36, down from CNY 2,604,966,687.48, reflecting a reduction of 26.1%[19]. - The operating profit for the current period is CNY -24,346,511.60, compared to CNY 43,014,941.37 in the previous period, indicating a significant decline[19]. - Net profit for the current period is CNY -3,204,728.92, a sharp drop from CNY 42,612,804.20 in the previous period[19]. - The total profit for the period was -¥24,569,100, a decline of 153.66% year-on-year, attributed to decreased market demand and production losses[9]. Cash Flow - The cash flow from operating activities for the year-to-date was ¥479,231,453.45, reflecting a significant increase of 318.95%[4]. - The net cash flow from operating activities for Q3 2022 was ¥479,231,453.45, a significant increase from ¥114,389,534.33 in Q3 2021, representing a year-over-year growth of approximately 318%[23]. - The total cash inflow from financing activities was ¥1,701,517,157.78, compared to ¥2,048,039,961.47 in the same period last year, indicating a decrease of about 17%[23]. - The net cash flow from financing activities was ¥44,923,340, a decrease of 42.67% compared to the previous year[9]. - The net cash flow from investment activities was -¥320,643,049.99, worsening from -¥93,743,893.55 in Q3 2021, reflecting increased cash outflows for investments[23]. - The cash outflow for purchasing goods and services was ¥1,435,839,611.44, down from ¥2,061,837,952.99 in Q3 2021, showing a reduction of about 30%[23]. - The cash paid for employee compensation was ¥135,089,722.15, slightly up from ¥133,605,219.89 in Q3 2021, reflecting a marginal increase of about 1.1%[23]. - The net increase in cash and cash equivalents for Q3 2022 was ¥610,627,173.10, compared to ¥802,277,985.67 in Q3 2021, representing a decrease of approximately 23.9%[24]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,581,216,662.49, representing a 2.55% increase from the end of the previous year[4]. - Total liabilities amount to CNY 3,467,138,765.60, an increase from CNY 3,305,402,915.23 in the previous period[19]. - Total equity attributable to shareholders of the parent company is CNY 2,109,939,114.02, slightly down from CNY 2,132,833,741.80[19]. - The company's inventory decreased by 38.53% to ¥312,707,700, primarily due to reduced production and lower raw material prices[7]. - Accounts receivable decreased to ¥315,245,710.38 from ¥438,183,705.31, a decline of about 28.1%[16]. - Inventory decreased to ¥312,707,667.25 from ¥508,750,765.07, a reduction of approximately 38.5%[16]. - Short-term borrowings increased by 51.69% to ¥1,766,731,300, driven by the need for funding for ongoing projects[7]. - Short-term borrowings rose to ¥1,766,731,281.30 from ¥1,164,736,722.19, an increase of approximately 51.8%[16]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 72,662[11]. - Jiangsu Baoyuan Investment Management Co., Ltd. holds 19.66% of shares, making it the largest shareholder with 144,584,000 shares[12]. - The first major shareholder, Jiangsu Baoyuan Investment Management Co., Ltd., is also linked to the actual controller, Mr. Rui Jinggong, who is the chairman of the company[12]. - The company has established an employee stock ownership platform through Nanjing Baocheng Enterprise Management Center (Limited Partnership)[12]. Investment and Development - The company reported a significant increase in investment income to ¥10,609,400, mainly from cash management of idle funds[8]. - The company plans to expand its epoxy propylene production capacity from 100,000 tons to 250,000 tons through a technical upgrade[13]. - The company is actively exploring the domestic and international markets for isopropanol amine to enhance product profitability[9]. Research and Development - The company reported a decrease in research and development expenses to CNY 77,008,821.94 from CNY 84,205,704.30, a reduction of 8.5%[19]. Earnings Per Share - Basic and diluted earnings per share for the current period are both CNY -0.0042, compared to CNY 0.07 in the previous period[20]. - Other comprehensive income after tax for the current period is CNY 1,399,498.31, compared to a loss of CNY 2,028,624.52 in the previous period[20].